LoadingLoadingCookies show us what works. Privacy
Cookies show us what works. Privacy
LoadingCookies show us what works. Privacy
27 funds hold it · Insiders net selling
Net selling: insiders sold $14.1M and bought $0 on the open market in 90 days (SEC Form 4). Congress: net selling of $1K to $15K in 180 days.
Analyst target and ratings are on paid plans
Unlock the full resultsLast report
Nov 3, 2026
Financial period
Third Quarter 2026
Earnings per share
$1.88 expected
Revenue
Company release
Fourth Quarter 2026E guidance
$1.82B
No comparable estimate
Estimates as of Nov 11, 2026
EPS expected
$1.87 to $1.96
Revenue expected
10 analysts
Last 30 days
Analysts raising estimates
Estimate drift
Change in 30 days
| Quarter / reported | Earnings per share | Beat or miss | Revenue / income | Revenue vs last year |
|---|---|---|---|---|
| Sep 30, 2026Reported Nov 3, 2026 | $2.09est. $1.88 | +11.46%beat | $1.87BCompany release | +4.1%from $1.79B |
| Jun 30, 2026Reported Aug 4, 2026 | $1.88est. $1.76 | +6.75%beat | $1.82BSEC filing | +4.0%from $1.75B |
| Mar 31, 2026Reported May 5, 2026 | $1.65est. $1.45 | +13.58%beat | $1.68BSEC filing | +4.3%from $1.61B |
| Dec 31, 2025Reported Feb 10, 2026 | $1.38est. $1.29 | +6.60%beat | $1.69BSEC filing | +0.2%from $1.69B |
| Sep 30, 2025Reported Nov 6, 2025 | $3.27est. $2.94 | +11.22%beat | $1.79BSEC filing | +4.7%from $1.71B |
| Jun 30, 2025Reported Aug 5, 2025 | $3.36est. $3.18 | +5.66%beat | $1.75BSEC filing | +1.9%from $1.72B |
| Mar 31, 2025Reported May 2, 2025 | $3.09est. $2.86 | +8.04%beat | $1.61BSEC filing | +0.8%from $1.60B |
| Dec 31, 2024Reported Feb 11, 2025 | $3.39est. $2.94 | +15.31%beat | $1.69BSEC filing | -41.7%from $2.90B |
Earnings per share comes from Yahoo Finance where available, then Alpha Vantage or the company release. Revenue comes from company releases, SEC filings, Alpha Vantage or Yahoo Finance. A beat or miss needs an analyst estimate on the same basis as the reported figure, so quarters without one show none. Non-USD amounts carry their currency code.
| USD | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $1.69B | $1.68B | $1.82B | $1.87B |
| Cost of what it sold | $1.17B | $1.08B | $1.18B | $1.20B |
| Gross profit | $527.0M | $602.0M | $639.0M | $667.0M |
| What it spent | ||||
| Research and development | $38.0M | $47.0M | $42.0M | $42.0M |
| Sales and admin | $262.0M | $255.0M | $269.0M | $260.0M |
| Other operating costs | — | $114.0M | $72.0M | $89.0M |
| Total operating expenses | $300.0M | $416.0M | $383.0M | $391.0M |
| What was left | ||||
| Operating profit | $227.0M | $186.0M | $256.0M | $276.0M |
| Interest on debt | $61.0M | $40.0M | $41.0M | $40.0M |
| Profit before tax | -$66.0M | $181.0M | $266.0M | $279.0M |
| Tax | $42.0M | $31.0M | $75.0M | $108.0M |
| Net profit | -$126.0M | $161.0M | $143.0M | $123.0M |
| EBITDA | $154.0M | $306.0M | $359.0M | $474.0M |
This stock is in a strong uptrend, and looks overbought after a fast run-up.
Trend
Strong uptrend
85 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
Coverage leans bullish
Regulators order Chemours to ‘fully assess’ contamination
Leans bearishNov 12North Carolina Vows to Hold Chemours Accountable for Contamination ‘No Matter How Long It Takes’
BearishNov 11Dupont De Nemours stock hits all-time high of 158.5 USD
BullishNov 11Dupont De Nemours stock hits all-time high of 158.5 USD By Investing.com
BullishNov 11Fishy Moves – Is PFAS Manufacturer Moving to Hide the Money?
BearishNov 11DuPont Expands High-Purity Water Solutions With New EDI Modules
BullishNov 11DuPont Expands High-Purity Water Solutions With New EDI Modules
BullishNov 10CEO Of DuPont de Nemours Makes $349K Sale
Leans bearishNov 10
